There is a lack of information in the medical chemistry literature concerning the anti-influenza A activity of the drug rimantadine's 2-isomer (2rimantadine). We now present results showing that, although 2-adamantanamine (2-amantadine) 3 is only moderately active, some 2-rimantadine analogues are effective anti-influenza A virus agents in vitro. The 2-rimantadine analogues and their spirocyclobutane and spirocyclopentane congeners were synthesized through interesting routes. The 2-rimantadine analogues were 2-4 times more potent than rimantadine 2 against influenza virus A H 2 N 2 strain; their spirocyclobutane congeners proved equally active to rimantadine 2. Two compounds exhibited a similar activity and one of the compounds was was fourfold more potent than rimantadine 2 against H 3 N 2 strain.
Influenza epidemics occur during the winter months nearly every year and are responsible for an average of approximately 20000 deaths per year in the US (Cox & Subarao, 1999; Simonsen et al., 1996; Lui et al., 1987) . Influenza A viruses have the ability to undergo changes by the mechanisms of antigenic drift and shift and new evolving strains can be a serious threat to the human population (Taubenberger et al., 1997 (Taubenberger et al., , 2000 Horimoto et al., 2001) . The most lethal pandemic, the so-called Spanish influenza A of 1918-1919, caused the death of 20million people worldwide. The Asian influenza in 1957, Hong Kong influenza in 1968 and Russian influenza in 1977 also caused serious pandemics. Given that influenza shifts may occur every 20-30 years, and that a new lethal variant emerged in Hong Kong in 1997, the danger of future influenza A pandemics highlights the need to develop more effective drugs.
Amantadine 1 and rimantadine 2 are anti-influenza A drugs that inhibit virus replication at micromolar concentrations (Pinto et al., 1992; Hay et al., 1985 Hay et al., , 1992 ; their protonated form blocks the influenza A M2 ion channel protein (Duff et al., 1994; Pinto et al., 1997; Gandhi et al., 1999) . Some new drugs that are effective against both influenza A and B viruses have appeared in the market; they were based on DANA, the prototype neuraminidase inhibitor (Laughlin & Tseng, 1997) .
Our group has synthesized many potent aminoadamantane derivatives, mainly heterocycles and carbocycles, against influenza virus A (Laughlin & Tseng, 1997; Kolocouris et al., 1994; Kolocouris, 1995; Kolocouris et al., 1996; Kolocouris et al., 1999; Kolocouris et al., 2003) . 2-Adamantanamine 3 was not found to be an effective anti-influenza A agent (Kanele et al., 1972 (Kanele et al., , 1973 , which limited efforts to find an active 2rimantadine analogue. We now present results showing that, despite the fact that 2-amantadine 3 is moderately active, 2-rimantadine analogues 11, 13, 14, 21, 25, 26, 33 and 35 are potent anti-influenza A agents; some of these were more potent in vitro than rimantadine drug 2.
Materials and methods

Chemistry
Melting points were determined using a Büchi capillary apparatus and an uncorrected infrared (IR) spectra were recorded on a Perkin-Elmer 833 spectrometer. 1 H nuclear magnetic resonance (NMR) spectra were recorded on a Bruker AC 200 and MSL 400 spectrometers operating at 200 and 400 MHz, respectively, using CDCl 3 as solvent and TMS as internal standard. 13 C proton decoupled NMR
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Introduction spectra were recorded on a Bruker AC 200 spectrometer at 50 MHz using CDCl 3 as solvent and TMS as internal standard. Carbon multiplicities were established by DEPT experiments. The 2D NMR techniques (HMQC and COSY ) were used for the elucidation of the structures of some derivatives. The Service Central de Microanalyse (CNRS) France carried out microanalyses and the results obtained had a maximum deviation of ±0.4% from the theoretical value.
Details for the preparation of 2-adamantanecarboxaldehyde 6 and 2-adamantyl methyl ketone 8 and cyclobutanone 22 are presented in the literature (Farcasiu, 1972; Bernaert et al., 1973; van Leusen & van Leusen, 1978) . 2-Adamantanamine 3 was prepared by reductive amination of 2-adamantanone 4 (Borch et al., 1971) .
α-Methyl-2-tricyclo[3.3.1.1 3,7 ]decanemethanol (7). A benzene solution of 2-adamantanecarboxaldehyde 6 (prepared from 9.80 g or 60.0 mmol of epoxide 5) was added dropwise to a stirred solution of methylmagnesium iodide, prepared by the addition of a solution of methyl iodide (25.4 g, 0.179 mol) in dry ether (100 ml) to magnesium turnings (4.27 g, 0.179 gr-at). After stirring for 6 h, the mixture was hydrolysed under ice cooling by the addition of saturated NH 4 Cl solution. The aqueous phase was extracted with ether and the combined organic extracts were washed with water and dried (Na 2 SO 4 ). The organic solution was evaporated and petr. ether was added. The solution was cooled at -15°C and the precipitate was filtered off and washed with cold petr. ether (-15°C) to afford alcohol 7 (10.0 g, 93% from epoxide 5).
mp 76-78°C (ether-n-pentane); IR (Nujol) v (cm -1 ) 3300 (OH); δ H (CDCl 3 , 200 MHz) 1.15 (d, 3H, J ~6 Hz, CH 3 ), 1. 16H, 2, 3, 4, 5, 6, 7, 8, 9, OH) , 2.10 (br s, 1H, 1-H), 3.93-4.07 (m, 1H, CHOH). Anal. (C 12 H 20 O) C, H. 2-tricyclo[3.3.1.1 3,7 ]decyl ketoxime (9). Jones reagent (136.5 ml, 1 mmol/ ml) was added to a solution of alcohol 7 in acetone (90 ml) during a 1.5 h period under ice cooling. After stirring for 24 h at ambient temperature, isopropanol (10 ml) was added, and stirring was maintained for an additional 1 h. The reaction mixture was filtered off and the filtrate was evaporated in vacuo. Water was added to the residue and the mixture was extracted with ether. The combined organic extracts were washed with water, dried (Na 2 SO 4 ) and evaporated to afford ketone 8 (5.4 g, 80%); mp 30°C (ether-n-pentane); IR (Nujol) v (cm -1 ) 1710 (C=O).
Methyl
To a solution of ketone 8 (4.80 g, 27.0 mmol) in ethanol (45 ml) was added hydroxylamine hydrochloride (5.86 g, 84.0 mmol) and CH 3 COONa 3H 2 O (11.7 g, 87.0 mmol). The mixture was refluxed for 3 h and after cooling to ambient temperature water was added. The solid oxime formed was filtered off, washed with water and dried (5.30 g, quantitative yield). mp 155ºC (ether-n-pentane); IR (Nujol) v (cm -1 ) 3280 (OH), 1665 (C=N); δ H (CDCl 3 , 400 MHz) 1.54 (br d, 2H, J~ 13 Hz, 4eq, 9eq-H), 1. 75-1.96 (complex m, 10H, 4ax, 5, 6, 7, 8, 9ax , 10-H), 1.85 (s, 3H, CH 3 ), 2.22 (br s, 2H, 1, 3-H), 2.41 (br s, 1H, 2-H), 9.33 (s, 1H, OH); Anal. (C 12 H 19 NO) C, H. 7 ]decyl ketoxime (10). A mixture of oxime 9 (3.37 g, 17.5 mmol), acetic anhydride (30.6 g, 0.30 mol) and pyridine (57 ml) was stirred for 12 h at 0°C. Chloroform (100 ml) was added and the organic solution was washed with cold water (100 ml). The organic layer was washed with aqueous Na 2 CO 3 and water, dried (Na 2 SO 4 ) and evaporated in vacuo to afford the solid oximester 10 (4.0 g, quantitative yield). mp 77°C (hexane); IR (Nujol) v (cm -1 ) 1760 (C=O), 1638 (C=N); δ Η (CDCl 3 , 200 MHz) 1. J= 12.3 Hz, 2H, 4eq, 10H, 4ax, 5, 6, 7, 8, 9ax, 
O
11). Method A: NaBH 4 (2.27 g, 60.6 mmol) was added to a solution of oximester 10 (3.0 g, 12.7 mmol) in dry THF (40 ml). To the mixture was added under ice cooling a solution of iodine (5.60 g, 22.7 mmol) in dry THF (40 ml). The resulting solution was refluxed for 3 h, then HCl 3N was added under ice cooling and the solvent was evaporated under vacuum. Water (40 ml) was added and the mixture was made alkaline with aqueous KOH. The resulting mixture was extracted with chloroform and the combined organic extracts were washed with water and dried (Na 2 SO 4 ). After solvent evaporation, the viscous oily amine 11 was afforded (yield 39%).
Method B: To a mixture of ketone 8 (590 mg, 3.30 mmol), NaCNBH 3 (230 mg, 3.60 mmol) and anhydrous ammonium acetate (2.49 g, 32.3 mmol) in dry methanol (30 ml), 3 Å molecular sieves (3.0 g) were added and the suspension was gently stirred for 30 h. Then water was added, the suspension was filtered off and the filtrate was acidified with conc. HCl. Methanol was evaporated and the resulting mixture was extracted with ether and the aqueous phase was made alkaline with solid Na 2 CO 3 . The mixture was extracted with ether and the combined ether extracts were washed with water and dried (Na 2 SO 4 ). After solvent evaporation the oily amine 11 was obtained (yield 34%).
Method C: The ketoxime 9 (760 mg, 3.90 mmol) was dissolved in dry ethanol (30 ml) and fresh Raney-Nickel catalyst was added. The resulting suspension was hydrogenated for 20 h at 600 C under 50 psi. The catalyst was removed by filtration and the ethanol was evaporated to give amine 11 (590 mg, 70%). N, 7 ] decanemethanamine (13). To a solution of amine 11 (1.0 g, 5.50 mmol) and triethylamine (750 mg, 7.50 mmol) in dry ether (25 m;) was added a solution of ethylchloroformate (680 mg, 6.30 mmol) in dry ether (10 ml) under ice cooling. After an overnight stirring at room temperature the mixture was treated with an ice-water mixture and extracted with ether. The combined ether extracts were washed with water, cold HCl 3%, water and dried. Solvent evaporation afforded the solid carbamate 13 (1.44 g, quantitative yield); mp 110ºC (petr. ether); IR (Nujol) v (cm -1 ) 3318 (N-H), 1685 (C=O); δ H (CDCl 3 , 200 MHz) 1.09 (d, 3H, J ~6 Hz, α-CH 3 ), 1.20 (t, 3H, J ~7 Hz, CH 2 CH 3 ), 1.22-1.34 (m, 2H, 4eq, 9eq-H), 1. 46-2.0 (complex m, 13H, 1, 2, 3, 4ax, 5, 6, 7, 8, 9ax-H) , 3.92-4.21 (m, 3H, CH 2 CH 3 , CHN), 4.32 (br d, 1H, NH); Anal. (C 15 H 25 NO 2 ) C, H.
To a stirring suspension of LiAlH 4 (710 mg, 18.8 mmol) in dry THF (20 ml) was added dropwise a solution of carbamate 12 (1.2 g, 47.8 mmol) in dry THF (20 ml). After stirring for 24 h at room temperature, the mixture was hydrolysed at 0°C, filtered off and the filtrate was evaporated in vacuo. Ether was added, the solution was extracted with HCl 6% and the aqueous solution was washed with ether and made alkaline with solid Na 2 CO 3 . The oily product formed was extracted with ether and the combined ether extracts were washed with water, dried (Na 2 CO 3 ) and evaporated to afford the viscous oily amine 13 (900 mg, quantitative yield).
δ H (CDCl 3 , 200 MHz) 0.95 (d, 3H, J ~6 Hz, α-CH 3 ), 1.10 (br s, 1H, NH), 1.26 (br d, J=10 Hz, 2H, 4eq, 9eq-H), 1. 40-1.75 (complex m, 12H, 2, 3, 4ax, 5, 6, 7, 8, 9ax , 10-H), 1.89 (br s, 1H, 1-H), 2.35 (s, 3H, NCH 3 ), 2.63-2.77 (m, 1H, CHN); δ C (CDCl 3 , 50 MHz) δ (ppm) 16.8 (α-CH 3 ), 27.6 (7-C), 27.9 (5-C), 28.2 (3-C), 29.2 (1-C), 31.9, 32.0 (4,9-C), 33.7 (CH 3 N), 38.1 (6-C), 38.8, 39.2 (8, 10-C), 49.9 (CHN), 53.9 (2-C); Hydrochloride: mp 238ºC (EtOH-Et 2 O), anal. (C 13 H 24 NCl) C, H. N, N, 7 ]decanemethanamine (14). To a stirring solution of amine 11 (1.0 g, 5.50 mmol) in dry acetonitrile (15 ml) was added aqueous formaldehyde 37% (2 ml, 25.0 mmol) and then NaCNBH 3 (500 mg, 8.0 mmol). The mixture was stirred for 15 min and the pH was adjusted to 7 by the addition of acetic acid. Stirring was continued for 45 min with the occasional addition of acetic acid to maintain a neutral pH. Solvent was evaporated and KOH 2N (20 ml) was added. The mixture was extracted with ether and the combined organic extracts were washed with KOH 0.5 N and water and extracted with HCl 1N. The aqueous phase was made alkaline with the addition of KOH pellets, extracted with ether and the organic phase was dried (Na 2 CO 3 ). After solvent evaporation and flash chromatography on silica gel with CH 2 Cl 2 -CH 3 OH 10:1 as an eluent, the viscous oily amine 12 was obtained (500 mg, 44%). Methyl 2- (2-cyano-2-tricyclo[3.3.1.1 3,7 ]decyl)diazane-1-carboxylate (16). A mixture of 2-adamantanone 4 (8.0 g, 53.0 mmol), methyl hydrazinecarboxylate (4.8 g, 53.0 mmol) and acetic acid (2 drops) in dry methanol was refluxed for 1 h. Solvent was evaporated, petr. ether was added and methyl 2-(2-adamantylidene)carboxylate diazane 15 was precipitated after ice cooling. The solid material was filtered off and washed with petr. ether (11.9 g, quantitative yield); mp 128ºC (hexane); IR (Nujol) v (cm -1 ) 3238 (N-H), 1723 (C=O), 1654 (C=N); Anal.
(C 12 H 18 N 2 O 2 ) C, H. A mixture of hydrazone 15 (11.8 g, 53.0 mmol), NH 4 C l (8.5 g, 0.159 mol) and KCN (10.4 g, 0.159 mol) in water (37 ml) and methanol (25 ml) was stirred for 24 h at 30 0 C. Water was added, the mixture was extracted with dichloromethane and the organic phase was washed with water, dried (Na 2 SO 4 ) and evaporated. The viscous oily product was crystallized upon treatment with n-pentane and the solid material was filtered off and washed with cold pentane to afford diazane 16 (9.7 g, yield 80%). mp 112ºC (ether-pentane); IR (Nujol) v (cm -1 ) 3284 (N-H), 2224 (C=N), 1718 (C=O); δ H (CDCl 3 , 200 MHz) 1.50 (br d, 2H, J ~ 3 Hz, 4eq, 9eq-H), 1.68-2.10 (complex m, 10H, 1, 3, 5, 6, 7, 8, 10-H), 2.27 (br d, 2H, J ~12 Hz, 4ax, 9ax-H), 3.69 (s, 3H, CH 3 ), 4.13 (s, 1H, NH-C-C=N) 6.38 (s, 1H, NHCO); Anal. (C 13 H 19 
To a mixture of diazane 16 (9.35 g, 37.5 mmol), NaHCO 3 (9.35 g, 0.111 mol), dichloromethane (60 ml) and water (80 ml) was added dropwise a solution of bromine (6.66 g, 42.0 mmol) in dichloromethane (16 ml). The resulting orange solution was treated with small portions of sodium metabisulfite (Na 2 S 2 O 5 ) until the solution colour changed to light yellow. The organic phase was separated and the aqueous phase was extracted with dichloromethane. The combined organic extracts were washed with water, dried (Na 2 SO 4 ) and evaporated to give the viscous oily methyl 2-(2-cyano-2-adamantyl)diazene-1-carboxylate 17 which slowly crystallized on cooling and used without further purification for nitrile 18 preparation (9.23 g, quantitative yield); mp 41°C (methanol-pentane); IR (Nujol) v (cm -1 ) 2237 (C=N), 1774 (C=O), 1454 (N=N).
To a methanolic solution of sodium methoxide (34.0 mmol), prepared by the addition of sodium (780 mg, 34.0 mmol) to methanol (18 ml), was added dropwise (45 min) under ice cooling a solution of diazene 17 (17.11 g, 69.2 mmol) in methanol-ether 1:1 (35 ml). A vigorous reaction and gas formation was observed during the addition and the mixture was left to reach room temperature. Then water (50 ml) was added and the mixture was extracted with ether. The combined organic extracts were washed with water, dried (Na 2 SO 4 ) and evaporated to afford 2adamantanecarbonitrile 18 (10.7 g, 96%); mp 177ºC (hexane); this product had the same spectral characteristics and physical constants as those mentioned in the literature (Hoogenboom et al., 1988) .
To a solution of LDA, prepared by the addition of a solution of diisopropylamine (3.50 g, 35.0 mmol) in anhydrous ether (15 ml) to a solution of n-BuLi 2.5 M in hexanes (12 ml, 30.0 mmol) at -80ºC and stirring the resulting solution for 20 min under argon atmosphere, was added a solution of 2-adamantanecarbonitrile 18 (4.0 g, 25.0 mmol) in anhydrous THF (30 ml) at -80ºC. The mixture was stirred for 1.5 h, the temperature was raised at -65ºC and a solution of methyl iodide (14.9 g, 0.105 mol) was added dropwise. The mixture was allowed to warm at room temperature, stirred overnight, treated with an ice-water mixture and extracted with ether. The organic phase was washed with aqueous NaHSO 3 , and water, and dried (Na 2 SO 4 ). After solvent evaporation and filtration on silica gel using ethyl acetate/hexane 1:1 as an eluent, the solid nitrile 19 was afforded (4.20 g, 97% 
To a solution of MeLi 5% in ether (43 ml) was added dropwise under argon atmosphere at -40ºC a solution of nitrile 19 (3.80 g, 21.7 mmol) in anhydrous ether (40 ml). After reaching room temperature the reaction mixture was hydrolysed under ice cooling with water (40 ml). The organic phase was separated and the aqueous phase was extracted with ether. The combined organic extracts were washed with water, dried (Na 2 SO 4 ) and evaporated under vacuum. The residue was treated with HCl 18% (20 ml) and acetone (25 ml) and the mixture was heated to reflux for 1 h. The acetone was evaporated and the remaining aqueous mixture was made alkaline with solid Na 2 CO 3 and extracted with ether. The ether phase was washed with water, dried and evaporated to afford imine 20 (3.94 g, quantitative yield). 14H, 1, 3, 4, 5, 6, 7, 8, 9, -2-tricyclo[3.3.1.1 3,7 ]decanemethanamine (21). To a stirred suspension of LiAlH 4 (2.32 g, 61.0 mmol) in dry THF (20 ml) was added dropwise a solution of ketimine 20 (3.90 g, 20.4 mmol) in dry THF (20 ml), and the reaction mixture was gently refluxed under argon atmosphere for 80 h. The mixture was hydrolysed at 0ºC with water, NaOH 10% and water and the inorganic material was filtered off. The filtrate was evaporated and ether was added. The organic solution was extracted with HCl 6% and the aqueous phase was made alkaline with solid Na 2 CO 3 . The aqueous solution was extracted with ether and the ether solution was washed with water and dried (Na 2 SO 4 ). After solvent evaporation and flash chromatography on silica gel using dichloromethane/methanol 15:1 as an eluent, the oily amine 21 was obtained (1.15 g, 30%) the amount of unreacted imine 20 was 1.0 g.
2,α-Dimethyl
δH ( Spiro [cyclobutane-1,2′-tricyclo[3.3.1.1 3,7 ]decan]-2amine (25). A mixture of cyclobutanone 22 (2.80 g, 14.7 mmol), NH 2 OH·HCl (1.38 g, 20.0 mmol), CH 3-COONa·3H 2 O (3.40 g, 25.0 mmol) and ethanol (45 ml) was refluxed for 10 h. Water was added and the precipitated material was filtrated, washed with water and dried to afford quantitatively oxime 23; mp 150ºC (ether-petr. ether); IR (nujol) v (cm -1 ) 3280 (N-OH), 1679 (C=N); Anal. (C 13 H 19 NO) C, H.
A mixture of oxime 23 (2.30 g, 11.2 mmol), dry pyridine (40 ml) and acetic anhydride (20.8 g, 203.0 mmol) was stirred for 12 h at 0ºC and left overnight at 3ºC. Chloroform was added and the organic solution was washed with an ice-water mixture. The organic phase was washed with water, aqueous Na 2 CO 3 , water, dried (Na 2 SO 4 ) and evaporated to afford the oxime ester 24 as a viscous oil, which was slowly crystallized (2.55 g, 92%); mp 135°C (hexane); IR (nujol) v (cm -1 ) 1748 (C=O), 1661 (C=N).
To a solution of oxime ester 24 (2.30 g, 9.30 mmol) in dry THF (40 ml), NaBH4 (2.27 g, 60.0 mmol) was added. The stirred mixture was cooled at 0°C and a solution of I2 (5.60 g, 22.7 mmol) in dry THF (40 ml) was added dropwise. The mixture was refluxed for 8 h, acidified slowly with HCl 3N under ice-cooling, and evaporated. Water (40 ml) was added, the mixture was made alkaline with aqueous KOH and extracted with ether. The organic phase was washed with water and dried (Na 2 CO 3 ). After solvent evaporation and flash chromatography on silica gel using ether/methanol 9:1 as an eluent the amine 25 was obtained (800 mg, 45% starting from ketone 22). N- Methylspiro[cyclobutane-1,2′-tricyclo[3.3.1.1 3,7 ] decan]-2-amine (26). A mixture of CH 3 NH 2 ·HCl (4.25 g, 63.0 mmol), KOH (2.35 g, 42.0 mmol), cyclobutanone 22 (2.0 g, 10.50 mmol) and NaCNBH 3 (310 mg, 6.30 mmol) in methanol (25 ml) was stirred for 100 h at ambient temperature. After acidification with conc. HCl under ice-cooling, water (20 ml) was added and the mixture was washed with ether. The aqueous phase was made alkaline with solid KOH, extracted with ether and the organic phase was washed with water, dried (Na 2 CO 3 ) and evaporated in vacuo to afford a viscous oil. Flash chromatography on silica gel using ether/methanol 3:1 as an eluent gave oily amine 26 (1.20 g, 56%). 
2-(2-Propenyl)tricyclo[3.3.1.1 3,7 ]decane-2-carbonitrile
(27). To a solution of LDA in dry ether (15 ml), prepared by the addition of an ethereal solution of freshly distilled diisopropylamine (3.5 g, 35.0 mmol) to a solution of n-BuLi (12 ml 2.5 M or 30.0 mmol) in hexanes and stirring the resulting solution for 30 min at -80ºC under argon atmosphere, was added dropwise a solution of nitrile 18 (4.0 g, 24.8 mmol) in dry THF (20 ml) and the mixture was stirred for 1.5 h at -65ºC. Then a solution of freshly distilled allylbromide (12.7 g, 104.0 mmol) in dry THF (20 ml) was added and the mixture was stirred overnight and left to warm slowly at 25ºC. The mixture was treated with an ice-water mixture, extracted with ether and the organic phase was washed with water, dried (Na 2 SO 4 ) and evaporated in vacuo. After distillation under reduced pressure the oily nitrile 27 was obtained (this material was solidified at 3ºC) (4.39 g, 88%). bp 115ºC (2 mm.); IR (Nujol) v (cm -1 ) 1643 (C=C); δ H (400 MHz, CDCl 3 ) 1.57-1.84 (complex m, 12H, 1′,3′,4′eq,5′,6′,7′,8′,9′eq, 10-H), 2.20 (br d, J 12 Hz, 2H, 4′ax,9′ax-H), 2.50 (d, J= 12 Hz, 2H, 1-H), 5.13-5.21 (m, 2H, 3-H), 5.77-5.98 (complex m, 1H, 2-H).
2-(3-Bromopropyl)tricyclo[3.3.1.1 3,7 ]decane-2-carbonitrile (28).
A vigorously stirred solution of allylic derivative 27 (8.0 g, 40.0 mmol) and dibenzoylperoxide (380 mg, 1.60 mmol) in dry petr. ether (70 ml) was treated with Hbr gas, produced by the addition of bromine (5 ml) to tetraline (15 ml), at 10-15°C. The flow of HBr gas was maintained until a white precipitate was formed which made the reaction mixture viscous. The mixture was cooled at -20°C, filtered off, washed with cold petr. ether (-20°C) and dried to afford 10.7 g (95.5%) of crude bromonitrile 28 (this material can be purified by a filtration from a silicagel using ether-n/pentane 1:1 as an eluent). mp 96°C; IR (Nujol) v (cm -1 ) 2225 (C∫N); δ H (400 MHz, CDCl 3 ) 1.63-1.92 (complex m, 16H, 1, 2, 1′, 3′, 4′eq, 5′, 6′, 7′, 8′, 9′eq, 10′-H), 2.23 (br d, J= 12 Hz, 2H, 4′ax,9′ax-H), 3.46 (t, J=6 Hz, 2H, 3-H); Anal. (C 14 H 20 NBr) C, H.
2-(3-Cyanopropyl)tricyclo[3.3.1.1 3,7 ]decane-2-carbonitrile (29).
A mixture of bromonitrile 28 (15.0 g, 53.4 mmol), anhydrous KCN (12.1 g, 186.0 mmol) and 18-6 crown ether (1.6 g, 6.0 mmol) in dry acetonitrile (70 ml) was refluxed for 90 h (TLC monitoring using ether/THF 2:1). The mixture was cooled at room temperature, water was added and the precipitate formed was filtered off, washed with water and dried (12.0 g, quantitative yield). mp 131°C (methanol-ether); IR (Nujol) v (cm -1 ) 2228 (C=N); δ H (400 MHz, CDCl 3 ) 1.63-1.92 (complex m, 16H, 1, 2, 1′, 3′, 4′eq, 5′, 6′, 7′, 8′, 9′eq, 10′-H), 2.23 (br d, J=12 Hz, 2H, 4′ax, 9′ax-H), 2.43 (t, J=6.3 Hz, 2H, 3-H). Anal. (C 15 H 20 N 2 ) C, H.
-A m i n o s p i r o [ c y c l o p e n t e n e -3 , ′tricyclo[3.3.1.1 3,7 ]decan]-1-carbonitrile (30).
To a solution of LDA in dry ether (10 ml), prepared by the addition of an ethereal solution of freshly distilled diisopropylamine (2.10 g, 20.8 mmol) to a solution of n-BuLi (7.3 ml, 2.5 M or 18.2 mmol) in hexanes and stirring the resulting solution for 30 min at -80°C under argon atmosphere, was added dropwise a solution of dinitrile 29 (3.0 g, 13.0 mmol) in dry THF (20 ml) and the mixture was left overnight to slowly reach room temperature. The mixture was treated with an ice-water mixture, extracted with ether and the organic phase was washed with water, HCl 5%, water, dried (Na 2 SO 4 ) and evaporated in vacuo. The solid material obtained was treated with ether-n-pentane, filtered off and dried to afford the enamine 30 (2.43 g, 81%). Spiro [cyclopentane-1,2′-tricyclo[3.3.1.1 3,7 ]decan]-2one (31). A vigorously stirring mixture of enaminenitrile 30 (1.71 g, 7.50 mmol) and 33% H 2 SO 4 (30 ml) was gently refluxed; a white material appeared. After 1 h refluxing, glacial acetic acid (15 ml) was added, the mixture was refluxed for an additional 20 h period and cooled at room temperature. Water was added, the mixture was extracted with ether and the organic phase was washed with water, aqueous Na 2 CO 3 , water, and dried (Na 2 SO 4 ). After solvent evaporation, the viscous oily material was filtered through silica gel to afford ketone 31 (1.54 g, quantitative yield). mp 39°C (petr. ether cooled at -20°C); IR (Nujol) v (cm -1 ) 1730 (C=O); δ Η (400 MHz, CDCl 3 ) 1. 36-2.0 (complex m, 16H, 4, 5, 1′ ,3′, 4′eq, 5′, 6′, 7′, 8′, 9′eq, 10-H) Spiro [cyclopentane-1,2′-tricyclo[3.3.1.1 3,7 ]decan]-2one oxime (32). A mixture of ketone 31 (1.25 g, 6.10 mmol), NH 2 OH·HCl (550 mg, 8.80 mmol) and CH 3 COONa·3H 2 O (1.22 g, 9.0 mmol) and ethanol 93% (30 ml) was refluxed for 30 h. The mixture was cooled at room temperature, water was added and the precipitate formed was filtered of, washed with water and dried (1.3 g, quantitative yield). mp 100ºC (petr. ether); IR (Nujol) v (cm -1 ) 3337 (OH), 1647 (C=N); δ Η (400 MHz, CDCl 3 ) 1.50-2.01 (complex m, 16H, 4, 5, 2′, 3′, 4′eq, 5′, 6′, 7′, 8′, 9′eq, 10-H), 2.46-2.59 (m, 4H, 3-H, 4′ax, 9′ax-H), 7.45 (NOH); δ C (CDCl 3 , 50 MHz) 19.0 (4-C), 26.7 (5-C), 27.5 (7′-C), 27.6 (5′-C), 33.0 (4′, 9′-C), 33.5 (1′, 3′-C), 34.3 (8′,10′-C), 37.4 (6′-C), 39.1 (3-C), 51.7 (1,2′-C), 171.6 (2-C). Anal. (C 14 H 21 NO) C, H. -1,2′-tricyclo[3.3.1.1 3,7 ]decan]-2amine (33). A solution of oxime 32 (2.31 g, 10.5 mmol) in dry ethanol was hydrogenated using Ni-Raney catalyst for 3.5 h, at 70°C, and under pressure (50 psi). The catalyst was filtered off and the solvent was evaporated under vacuum to afford the viscous oily amine 33 (2.23 g, quantitative yield). [cyclopentane-1,2′-tricyclo[3.3.1.1 3,7 ] decan]-2-amine (35). To a solution of amine 33 (1.28 g, 6.29 mmol) and triethylamine (2.50 g, 24.9 mmol) in dry ether (25 ml) was added a solution of ethyl chloroformate (2.01 g, 18.6 mmol) in dry ether (20 ml). The mixture was stirred for 24 h at 25°C, poured into an ice-water mixture and extracted with ether. The organic phase was washed with water, cold HCl 3%, and water, dried (Na 2 SO 4 ) and evaporated in vacuo. The solid material obtained was filtered through silica gel to afford solid carbamate ester 34 (1.70 g, quantitative yield); mp 95ºC (petr. ether cooled at -20ºC).
Spiro[cyclopentane
N-Methylspiro
A solution of carbamate 34 (1.69 g, 6.10 mmol) in dry THF (20 ml) was added dropwise under ice cooling to a suspension of LiAlH 4 (694 mg, 18.3 mmol) in dry THF (20 ml). The mixture was stirred for 24 h at 25ºC, hydrolysed with water and Na 2 CO 3 5%, filtered off and evaporated in vacuo. Ether was added, the organic solution was dried (Na 2 CO 3 ) and the solvent was removed to afford the viscous oily amine 35 (1.40 g, quantitative yield). 
Virology
Cells and viruses. Influenza A and B viruses were kindly provided by Dr K Andries ( Janssen Pharmaceutica, Beerse, Belgium) and stocks were prepared on MDCK cells.
Antiviral activity and cytotoxicity assays
Anti-influenza virus activity was assessed in 96 well plates on 1-day confluent MDCK cells. Cells were infected with 100CCID 50 virus/well. After 1 h of virus absorption virus was removed and serial dilutions of the test compounds were added after which cultures were further incubated at 35 C (5% CO 2 ) for 4-5 days. Cytopathic effect (and cytotoxic effect in parallel) in non-infected cultures were read using the MTS-method (Promega).
Results
Chemistry
The synthetic route followed for the preparation of the 2rimantadine analogues 11, 13, 14 and 21 is illustrated in Figures 1 and 2. 2-Adamantyl methyl ketone 8 was used as the starting material for the preparation of compounds 11, 13 and 14. The synthesis of this ketone was accomplished starting from 2-adamantanone 4 which was successively transformed to spiro [adamantane-2,2′-oxirane] 5 and aldehyde 6 (Farcasiu, 1972) . Due to its instability, this aldehyde was not isolated and was used promptly after its preparation for the synthesis of α−methyl-2-adamantanemethanol 7. In the past, this alcohol has been synthesized from the Grignard reaction between the epoxide 5 and methyl magnesium iodide (Bernaert et al., 1973) or between acetaldehyde and 2-adamantyl magnesium bromide (Yurchenko et al., 1987) . Alcohol 7 was oxidized with Jones reagent to the ketone 8 (van Leusen & van Leusen, 1978) . To obtain the parent 2-rimantadine 11, four different synthetic pathways were examined: a) reductive amination (CH 3 COONH 4 /NaCNBH 3 ) (Borch et al., 1971 ) of the ketone 8 afforded the desired amine in 34% yield; b) ketone 8 was treated with hydroxylamine to yield the oxime 9 (reduction of the latter with LiAlH 4 gave a mixture of the target amine 11 and N-methyl-2-adamatanemethanamine in a 2:3 ratio; the later amine was obtained from the reduction of the corresponding amide formed through a Beckmann rearrangement of the oxime 9); (c) because of the above problems, oxime 9 was transformed to its corresponding oxime ester 10, which was treated with NaBH 4 /I 2 in THF (Barbry & Champagne, 1995) to yield the amine 11 in 39% yield; and d) the catalytic hydrogenation of oxime 9 over Raney nickel catalyst gave the best results affording the 2-rimantadine 11 in good yield (70%). The synthesis of the amines 13 and 14 was achieved by the LiAlH4 reduction of the carbamate 12 and the Borch-Hassid reductive methylation of the parent amine 11 (Borch & Hassid, 1972) .
For the synthesis of the 2-methyl substituted 2-rimantadine 21, nitrile 18 was used as starting material (Figure 2) . Although nitrile 18 has been synthesized using tosylmethylisocyanide/t-BuOK (Oldenziel & van Leusen, 1972; Oldenziel et al., 1977; Hoogenboom et al., 1988) , we chose to prepare this important starting material through a simple four-step procedure used for the preparation of cyclohexanocarbonitrile (Ziegler & Wender, 1971 with a total yield higher than 80%. Thus, 2-adamantanone 4 was transformed to its corresponding hydrazone 15. The addition of hydrogen cyanide to hydrazone 15 led to the cyanodiazane 16, which was dehydrogenated to the cyanodiazene 17 using Br 2 /NaHCO 3 . Treatment of compound 17 with sodium methoxide afforded the 2-cyanoadamantane 18. Lithiation at 2-position of 18 by means of LDA and reaction of the resulting carbanion with methyl iodide gave the 2-methyl-2-cyanoadamantane 19. It is known from the literature that the addition of methyl lithium to 2cyanoadamantane yielded 2-adamantyl methyl ketone (van Leusen & van Leusen, 1978) . However, methyl lithium treatment of cyanoderivative 19 yielded the imine 20 instead of the expected ketone. Attempts to hydrolyse imine 20 even with HCl 18% to the desired ketone proved unsuccessful because of the increased crowding around the C=N bond. Finally the synthesis of amine 21 was achieved in moderate yield (30%) by means of LiAlH 4 reduction of the imine 20.
The synthesis of the cyclobutane 2-rimantadine analogues 25 and 26 is illustrated in Figure 3 and was accomplished by using cyclobutanone 22 as a starting material. This compound was prepared, according to a literature procedure (Bernaert et al., 1973) , by the reaction of 2-adamantanone 4 with the tetrafluoroborate of the diphenylsulfonium cyclopropylide; the intermediate oxaspiropentane was rearranged to the cyclobutanone 22 upon treatment with HBF 4 . Raney-Ni hydrogenation of the ketone oxime 23 gave a mixture of products, due to hydrogenolysis of cyclobutane ring; in addition, its reductive amination using NaCNBH 3 resulted in the desired amine 25 in only 1% yield. Finally, the target amine was successfully synthesized by the borane reduction of the oxime ester 24 using NaBH 4 /I 2 in THF. Reductive amination (CH 3 NH 2 / NaCNBH 3 ) of the ketone 22 resulted in the N-methyl derivative 26 (Borch et al., 1971) (Figure 4) . Figure 5 depicts the synthesis of the cyclopentane 2rimantadine analogues 33 and 35. Allylation of 2-adamantanecarbonitrile 18 and subsequent anti-Markownikoff addition of HBr to 2-(2-propenyl)adamantane-2-carbonitrile 27 led to the 2-(3-bromopropyl) derivative 28. The transformation of 2-(3-bromopropyl)adamantane-2-carbonitrile 28 to the pure dinitrile 29 was accomplished using KCN/18-crown-6 in refluxing CH 3 CN. The dinitrile 29 was transformed to the cyanoenamine 30 through Thorpe-Ziegler reaction (Ziegler & Wender, 1971 Schaefer & Bloomfield, 1967; Kulp, 1967) , using LDA in THF-ether. Acidic hydrolysis of enamine 30 with 33% H 2 SO 4 led to the key cyclopentanone 31. The desired amines 33, 35 were prepared through Ni-Raney hydrogenation of the ketone oxime 32. The above procedure can be used for the synthesis of complex spiroketones starting from a nitrile with a structure corresponding to the most complex spiromotif, and then building the ketone ring.
Discussion
The in vitro cytotoxicity and antiviral activity of the new aminoadamantane derivatives were examined against influenza virus A strains H 2 N 2 , H 3 N 2 , and influenza B according to previously reported methods (Shigeta et al., 1988) . Amantadine 1, rimantadine 2, 2-amantadine 3 and ribavirin were included as controls (Table 1) . Influenza virus A H 2 N 2 is a strain with exquisite sensitivity to amantadine 1 and rimantadine 2.
Influenza virus A H 2 N 2 :
From the EC 50 values presented in Table 1 , it is evident that, 2-rimantadines 11, 13, 21 were 2-4 times more potent than rimantadine drug 2 and their spirocyclobutane congeners 25 and 26 were equally active to rimantadine 2.
The 2-amantadine 3 was also included as a control and its moderate activity was confirmed. Interestingly, whereas 2-adamantyl substitution with an amino group resulted in the moderately active 2-amantadine 3, 1aminoethyl substitution resulted in the potent inhibitor, 2-rimantadine 11. 2-Rimantadine 11 was 67-fold more potent than 2-amantadine 3 in vitro. N-Methyl substitution of the parent compound 2rimantadine 11 resulted in the equally potent derivative 13, whereas N,N-dimethyl substitution (compound 14) caused a six-fold reduction in potency (Table 1) .
Methyl substitution at 2-adamantyl position of 2rimantadine 11 resulted in compound 21, which was twofold less potent than the parent amine 11. Cyclobutane 2rimantadine analogues 25 and 26 both had similar potency to that of rimantadine 2, proved 2-fold less potent than their acyclic congener 21 and about 4-fold less potent than the parent 2-rimantadine 11. Ring enlargement resulted in spirocyclopentane analogues 33 and 35 which were threefold less potent than their cyclobutane analogues 25 and 26. Overall it appears as if increasing the carbon crowding around the C2-C1′ bond of the parent 2-rimantadine 11 leads to compounds with reduced antiviral potency.
Influenza virus A H 3 N 2 :
All the aminoadamantanes tested exhibited lower activity against this strain as was expected. 2-Rimantadine 11 was 1.6-fold less potent than rimantadine 2 and many times more potent than 2-amantadine 3. It is noteworthy that 2-methyl-2-rimantadine 21 exhibited a fourfold higher potency with respect to rimantadine 2; its spirocyclopentane analogue 33 was about 1.5 more active than rimantadine 2. It appears that 2-methyl substitution of 2-rimantadine 11 increase the antiviral potency. Overall, 2-rimantadines 11, 21, 33 exhibited good activities against both influenza A strains. Influenza virus B: All the compounds were inactive 1, 2, 3, 11, 13, 14, 21, 25, 26, 33 against influenza B virus; this is in accordance with their mode action that is targeted at influenza A M2 protein (not present in influenza B virions). The new compounds were synthesized and tested in their racemic form. It has been reported that different configuration of chiral center of rimantadine 2 didn't affect anti-influenza virus A potency (Aldrich et al., 1971) .
In conclusion, this work reports the synthesis of 2-rimantadine analogues. It was shown, that although 2-amantadine 3 was moderately potent against influenza A, 2- rimantadine analogues 11, 13, 14, 21, 25, 26, 33, 35 were potent agents in vitro against influenza A virus. In particular 2-rimantadines 11 and 13, which are isomeric in structure with rimantadine drug 2, and 2-methyl-2-rimantadine 21 were found to be about fourfold and twofold respectively more potent than the latter against influenza virus A H 2 N 2 ; 2-rimantadine 11 and 2-methyl-2-rimantadine 21 exhibited a similar and a fourfold higher potency than rimantadine 2 respectively against H 3 N 2 strain. These results may open new perspectives for the design of more effective aminoadamantanes.
